Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers

Osteoarthritis (OA) is a painful disease for which drug development has proven difficult. One major reason for this is the heterogeneity of the disease and the current lack of operationalized means to distinguish various disease endotypes (molecular subtypes). Biomarkers measured in blood or urine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bay-Jensen, Anne C., Mobasheri, Ali, Thudium, Christian S., Kraus, Virginia B., Karsdal, Morten A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
OSTEOARTHRITIS: Edited by Mukundan Attur
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635261/
https://www.ncbi.nlm.nih.gov/pubmed/34652292
http://dx.doi.org/10.1097/BOR.0000000000000845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635261/
https://www.ncbi.nlm.nih.gov/pubmed/34652292
http://dx.doi.org/10.1097/BOR.0000000000000845

Ejemplares similares